• Profile

Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

BMC Urology Sep 12, 2017

Pilskog M, et al. - Keeping the objective in mind, researchers demonstrated that baseline C-reactive protein was a significant predictive factor of sunitinib response and a prognostic factor of survival. It was considered that baseline C-reactive protein might be a useful biomarker in the treatment planning of metastatic renal clear cell carcinoma. Due to the relatively small sample size, the outcomes need to be confirmed in larger studies.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen